Literature DB >> 5942772

Microcirculation of tumors. I. Anatomy, function, and necrosis.

P Rubin, G Casarett.   

Abstract

Entities:  

Mesh:

Year:  1966        PMID: 5942772     DOI: 10.1016/s0009-9260(66)80027-2

Source DB:  PubMed          Journal:  Clin Radiol        ISSN: 0009-9260            Impact factor:   2.350


× No keyword cloud information.
  33 in total

1.  Depletion of topoisomerase II in isolated nuclei during a glucose-regulated stress response.

Authors:  J W Shen; J R Subjeck; R B Lock; W E Ross
Journal:  Mol Cell Biol       Date:  1989-08       Impact factor: 4.272

Review 2.  Causes and effects of heterogeneous perfusion in tumors.

Authors:  R J Gillies; P A Schornack; T W Secomb; N Raghunand
Journal:  Neoplasia       Date:  1999-08       Impact factor: 5.715

Review 3.  Nanomedicinal strategies to treat multidrug-resistant tumors: current progress.

Authors:  Xiaowei Dong; Russell J Mumper
Journal:  Nanomedicine (Lond)       Date:  2010-06       Impact factor: 5.307

4.  [Blood circulation and oxygen consumption of tissue-isolated implanted tumors (DS-carcinosarcoma) in vivo].

Authors:  W Schwarz; V Schulz; M Kersten; R Wörz; P Vaupel
Journal:  Z Krebsforsch       Date:  1971-02-26

5.  A physiological study of isolated human tumours.

Authors:  J A McKinna
Journal:  Ann R Coll Surg Engl       Date:  1970-02       Impact factor: 1.891

6.  The vascular architecture of human xenotransplanted tumors: histological, morphometrical, and ultrastructural studies.

Authors:  F Steinberg; M A Konerding; C Streffer
Journal:  J Cancer Res Clin Oncol       Date:  1990       Impact factor: 4.553

7.  Clinical requirements for localized hyperthermia in the patient.

Authors:  D E Thrall
Journal:  Radiat Environ Biophys       Date:  1980       Impact factor: 1.925

8.  Geographical mapping of metabolites in biological tissue with quantitative bioluminescence and single photon imaging.

Authors:  W Mueller-Klieser; S Walenta
Journal:  Histochem J       Date:  1993-06

Review 9.  Drug delivery and transport to solid tumors.

Authors:  Seong Hoon Jang; M Guillaume Wientjes; Dan Lu; Jessie L S Au
Journal:  Pharm Res       Date:  2003-09       Impact factor: 4.200

Review 10.  Biological barriers to therapy with antisense and siRNA oligonucleotides.

Authors:  R Juliano; J Bauman; H Kang; X Ming
Journal:  Mol Pharm       Date:  2009 May-Jun       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.